Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-014728
Filing Date
2022-05-23
Accepted
2022-05-23 12:52:34
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1140536
2 ex31-1.htm EX-31.1 14440
3 ex32-1.htm EX-32.1 7555
  Complete submission text file 0001493152-22-014728.txt   6108955

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE qnta-20220331.xsd EX-101.SCH 41872
5 XBRL CALCULATION FILE qnta-20220331_cal.xml EX-101.CAL 57045
6 XBRL DEFINITION FILE qnta-20220331_def.xml EX-101.DEF 229875
7 XBRL LABEL FILE qnta-20220331_lab.xml EX-101.LAB 391546
8 XBRL PRESENTATION FILE qnta-20220331_pre.xml EX-101.PRE 318299
56 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 915710
Mailing Address 632 S GLENWOOD PL BURBANK CA 91506
Business Address 632 S GLENWOOD PL BURBANK CA 91506 (818) 940-1617
QUANTA INC (Filer) CIK: 0001691430 (see all company filings)

EIN.: 812749032 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56025 | Film No.: 22950593
SIC: 2833 Medicinal Chemicals & Botanical Products